TScan Therapeutics Inc (TCRX)
7.73
-0.05
(-0.64%)
USD |
NASDAQ |
May 10, 12:22
TScan Therapeutics Price to Book Value: 2.709 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.726 |
| May 08, 2024 | 2.807 |
| May 07, 2024 | 3.038 |
| May 06, 2024 | 3.087 |
| May 03, 2024 | 2.999 |
| May 02, 2024 | 3.031 |
| May 01, 2024 | 3.020 |
| April 30, 2024 | 2.705 |
| April 29, 2024 | 2.691 |
| April 26, 2024 | 2.565 |
| April 25, 2024 | 2.554 |
| April 24, 2024 | 2.586 |
| April 23, 2024 | 2.424 |
| April 22, 2024 | 2.378 |
| April 19, 2024 | 2.277 |
| April 18, 2024 | 2.197 |
| April 17, 2024 | 2.143 |
| April 16, 2024 | 2.264 |
| April 15, 2024 | 2.442 |
| April 12, 2024 | 2.461 |
| April 11, 2024 | 2.477 |
| April 10, 2024 | 2.296 |
| April 09, 2024 | 2.366 |
| April 08, 2024 | 2.331 |
| April 05, 2024 | 2.251 |
| Date | Value |
|---|---|
| April 04, 2024 | 2.251 |
| April 03, 2024 | 2.274 |
| April 02, 2024 | 2.286 |
| April 01, 2024 | 2.543 |
| March 28, 2024 | 2.52 |
| March 27, 2024 | 2.634 |
| March 26, 2024 | 2.536 |
| March 25, 2024 | 2.517 |
| March 22, 2024 | 2.545 |
| March 21, 2024 | 2.225 |
| March 20, 2024 | 2.225 |
| March 19, 2024 | 2.212 |
| March 18, 2024 | 2.168 |
| March 15, 2024 | 2.260 |
| March 14, 2024 | 2.155 |
| March 13, 2024 | 2.130 |
| March 12, 2024 | 2.146 |
| March 11, 2024 | 2.082 |
| March 08, 2024 | 2.079 |
| March 07, 2024 | 2.266 |
| March 06, 2024 | 2.269 |
| March 05, 2024 | 2.231 |
| March 04, 2024 | 2.260 |
| March 01, 2024 | 2.285 |
| February 29, 2024 | 2.14 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2722
Minimum
May 09 2022
3.087
Maximum
May 06 2024
0.9488
Average
0.6731
Median
Dec 22 2021
Price to Book Value Benchmarks
| AnaptysBio Inc | 7.391 |
| CEL-SCI Corp | 6.315 |
| AIM ImmunoTech Inc | 2.274 |
| IGC Pharma Inc | 3.731 |
| NovaBay Pharmaceuticals Inc | 1.779 |
Price to Book Value Related Metrics
| PS Ratio | 24.01 |
| Price | 7.73 |
| Earnings Yield | -23.16% |
| Market Cap | 408.63M |